Johnson & Johnson (JNJ)
Last updated: 2026-10-29 09:58:00. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.
Summary
Johnson & Johnson (JNJ) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NYSE. The stock is currently priced at $273.82, with a market capitalization of $646.92B and a P/E ratio of 40.54. Over the past 52 weeks, its price has ranged from $184.66 to $281.07. This page covers its latest market performance, valuation, price trends and company information.
Key Market Data
$646.92B | |
$273.32 | |
$281.07 | |
$46.25 | |
$271.04 | |
4.67K | |
6.87M | |
40.54 | |
$281.07 | |
$184.66 | |
1.95% | |
2001-12-27 |
Johnson & Johnson (JNJ) Pre-Market Stock Price
Johnson & Johnson (JNJ) is trading at $273.82 in pre-market trading as of 2026-10-29 09:54:00, up 1.02% ($2.77) from the previous close of $271.04
Pre-market trading shows how investors are pricing JNJ before the regular session opens. The current pre-market price is above the previous close, indicating positive early trading sentiment.
Johnson & Johnson (JNJ) 7-Day Stock Price Change
Over the past seven days, Johnson & Johnson (JNJ) moved from $259.36 to $273.82, representing a gain of 5.57% ($14.45).
The stock traded between $254.56 and $275.00 during the period. The latest price is near the upper end of the 7-day range, indicating strong upward.
The average daily volume was 6.80 million shares, down versus the previous seven-day period, indicating lower trading activity.
JNJ 52-Week Price Position
Position in Range: 92.5%
JNJ is currently trading at $273.82, placing it 92.5% of the way from its 52-week low of $184.66 to its 52-week high of $281.07. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
What is Johnson & Johnson (JNJ)?
Johnson & Johnson is the world's largest and most diverse healthcare firm. It has two divisions: innovative medicine and medtech. These now represent all of the company's sales following the divestment of the consumer business, Kenvue, in 2023. After restructurings in 2023-24, the drug division focuses on three main therapeutic areas: immunology, oncology, and neurology. Geographically, just over half of total revenue is generated in the United States.
Johnson & Johnson Information
| Industry | PHARMACEUTICAL PREPARATIONS |
| Employees | 140800 |
| CEO | Joaquin Duato |
| Founded | 1886 |
| Exchange | NYSE |
| Company Website |
How to Buy Johnson & Johnson (JNJ) Stock on MEXC
Eligible investors can buy real shares of Johnson & Johnson (JNJ) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Frequently Asked Questions (FAQ)
1.What is Johnson & Johnson (JNJ) stock price today?
2.Is JNJ stock going up or down today?
3.What is JNJ pre-market price?
4.What is JNJ after-hours price?
5.Is JNJ stock trading now?
6.Where does JNJ sit relative to its 52-week high and low?
7.What sector is Johnson & Johnson in?
8.What is Johnson & Johnson's market capitalization and where is it listed?
9.How is JNJ valued in terms of P/E ratio and EPS?
10.Does Johnson & Johnson pay a dividend?
Explore More US Stocks
Search Stocks
JNJ Stock Calculator
Estimate the value between JNJ shares and USD.
JNJ Shares to USD
1.00 JNJ shares = 273.815 USD
Calculations are estimates based on the latest available price and are for reference only.


